Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
Precision OpticsPOCI -5.72%73 EBITDA Margin % is 0.13% as of Mar. 2026. GuruFocus rates POCI with a GF Score™ of 73/100 and a GF Value™ of $6.34 (Modestly Undervalued). The stock has 5 warning signs investors should review. Among 816 Medical Devices & Instruments companies, Precision Optics ranks worse than 70.83% on this metric.
EBITDA Margin % is calculated as EBITDA divided by its Revenue. Precision Optics's EBITDA for the
three
months ended in Mar. 2026 was $0.01 Mil. Precision Optics's Revenue for the
three
months ended in Mar. 2026 was $8.71 Mil. Therefore, Precision Optics's EBITDA margin for the quarter that ended in Mar. 2026 was 0.13%.
EBITDA Margin % is the ratio of EBITDA divided by net sales or Revenue. It is an performance metric measuring company's operating profitability. EBITDA Margin takes depreciation and amortization, interest expense and tax into account, which makes it easy to compare the relative profitability of companies of different sizes in the same industry.
Precision Optics EBITDA Margin % Related Terms
Precision Optics EBITDA Margin % Historical Data
* Premium members only.
The historical data trend for Precision Optics's EBITDA Margin % can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
POCI vs DXR, NEPH, MLSS: EBITDA Margin % Comparison
For the Medical Instruments & Supplies subindustry, Precision Optics's EBITDA Margin %, along with its competitors' market caps and EBITDA Margin % data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Precision Optics EBITDA Margin % vs Medical Devices & Instruments Industry
For the Medical Devices & Instruments industry and Healthcare sector, Precision Optics's EBITDA Margin % distribution charts can be found below:
* The bar in red indicates where Precision Optics's EBITDA Margin % falls into.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Precision Optics (POCI) has a EBITDA Margin % of 0.13% as of Mar. 2026. EBITDA Margin is the ratio of EBITDA divided by net sales or Revenue, usually presented in percent. View historical data on Precision Optics and its competitors. According to the industry distribution chart, Precision Optics ranks #578 out of 816 companies in the Medical Devices & Instruments industry, placing it in the top 70.8%.
Is Precision Optics' EBITDA Margin % too high?
Precision Optics' current EBITDA Margin % is 0.13%. The Medical Devices & Instruments industry median EBITDA Margin % is 7.46. Precision Optics' value of 0.13% is 98.3% below this industry median. Based on the distribution chart, Precision Optics ranks #578 out of 816 companies in the Medical Devices & Instruments industry, which is below the industry midpoint. Overall, Precision Optics has a GF Score™ of 73/100 and is considered Modestly Undervalued, reflecting its overall financial health beyond just this single metric.
How does Precision Optics' EBITDA Margin % compare to DXR and NEPH?
According to the Medical Devices & Instruments industry distribution chart, Precision Optics ranks #578 out of 816 companies for EBITDA Margin %. This places Precision Optics in the lower half of its industry. The industry median EBITDA Margin % is 7.46. Precision Optics' value of 0.13% is 98.3% below this benchmark. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good EBITDA Margin % for a Medical Devices & Instruments company?
The median EBITDA Margin % among Medical Devices & Instruments companies is 7.46, based on 816 companies in the industry. Companies in the top quartile (top 25%) have a EBITDA Margin % significantly above this median, while those in the bottom quartile fall well below. However, EBITDA Margin % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Precision Optics's current EBITDA Margin % of 0.13% is 98.3% below the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high EBITDA Margin % mean?
A high EBITDA Margin % can signal that a stock is expensive relative to its fundamentals. EBITDA Margin is the ratio of EBITDA divided by net sales or Revenue, usually presented in percent. View historical data on Precision Optics and its competitors. For the Medical Devices & Instruments industry, the median EBITDA Margin % is 7.46 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Precision Optics's current EBITDA Margin % is 0.13%. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Precision Optics stock overvalued right now?
Based on GuruFocus' analysis, Precision Optics (POCI) is currently considered Modestly Undervalued. The stock's GF Value™ is $6.34, compared to a current price of $4.45 — trading 29.8% below its estimated fair value. The current EBITDA Margin % is 0.13% and 98.3% below the Medical Devices & Instruments industry median of 7.46. Precision Optics' overall GF Score™ is 73/100 with 5 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is EBITDA Margin % calculated?
EBITDA Margin % is calculated from a company's financial statements. For Precision Optics (POCI), the current EBITDA Margin % is 0.13% as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Precision Optics (POCI) Overvalued in 2026?
Based on GuruFocus' analysis, Precision Optics stock appears to be undervalued.
The current stock price of $4.45 is trading 29.8% below its estimated GF Value™ of $6.34.
GuruFocus considers Precision Optics to be Modestly Undervalued.
Key valuation signals for POCI:
EBITDA Margin %: 0.13%
GF Value™: $6.34 vs. price of $4.45 (29.8% below fair value)
Industry Position: 98.3% below the Medical Devices & Instruments median (#578 of 816)
No single metric tells the full story. See the POCI stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Precision Optics Corp Inc is engaged in designing, developing, and manufacturing advanced optical instruments. It manufactures medical products such as endoscopes and endocouplers which incorporate various optical technologies for use in a variety of minimally invasive surgical and diagnostic procedures. The company also produces endoscopes for various applications as well as designs and manufactures custom optical medical devices to satisfy customers' specific requirements. In addition, the company manufactures and sells components and assemblies specially designed for industrial and military use. The company earns the majority of its revenue from the United States.
73GF Score
Get the complete analysis for POCI
EBITDA Margin % is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
POCI has been successfully added to your 
